Male sexual disturbances in liver diseases: What do we know?

被引：17

作者：

Durazzo, M. ^{[1
]}

Premoli, A. ^{[1
]}

Di Bisceglie, C. ^{[2
]}

Bo, S. ^{[1
]}

Ghigo, E. ^{[2
]}

Manieri, C. ^{[2
]}

机构：

[1] Univ Turin, Dept Internal Med, Div Internal Med, I-10126 Turin, Italy

[2] Univ Turin, Dept Internal Med, Div Endocrinol, I-10126 Turin, Italy

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2010年 / 33卷 / 07期

关键词：

Erectile dysfunction; liver disease; liver therapy; seminal parameters; HEPATITIS-C VIRUS; ALCOHOLIC CIRRHOTIC MEN; ERECTILE DYSFUNCTION; ANTIVIRAL THERAPY; INFECTION; SPERM; TRANSPLANTATION; SEMEN; TRANSMISSION; PREDICTORS;

D O I：

10.1007/BF03346632

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The alterations of sexual function known as the erectile dysfunction are quite frequent among patients affected by liver diseases and they tend to increase in advanced liver failure. This process is directly linked to cirrhosis or its treatments, such as liver transplantation, or to certain drugs (e.g. beta-blockers). Independent of cirrhosis, other factors may cause sexual problems in these patients. Alcohol itself seems to worsen sexual function in the absence of cirrhosis. Viral hepatitis has an uncertain influence on male gonadic function and even antiviral therapy itself can worsen some seminal and hormonal parameters, although it is reversible. Quality of life may be greatly decreased in cases of cirrhosis where these alterations are present, so it is important to value and care for them, if possible. This review investigates the major male sexual disturbances in liver diseases of various origins. (J. Endocrinol. Invest. 33: 501-505, 2010) (c) 2010, Editrice Kurtis

引用

页码：501 / 505

页数：5

共 50 条

[1] Male sexual disturbances in liver diseases: What do we know?
M. Durazzo
A. Premoli
C. Di Bisceglie
S. Bo
E. Ghigo
C. Manieri
[J]. Journal of Endocrinological Investigation, 2010, 33 : 501 - 505
[2] Cerebrovascular diseases in Nigeria: what do we know and what do we need to know?
Ogungbo, BI
Gregson, B
Mendelow, AD
Walker, R
[J]. TROPICAL DOCTOR, 2003, 33 (01) : 25 - 30
[3] Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, Lu
Schnabl, Bernd
[J]. PHYSIOLOGY, 2020, 35 (04) : 261 - 274
[4] Liver transplantation for pregnancy-related liver diseases, pregnancy and sexual function after liver transplantation: What do we know?
Clavien, Pierre-Alain
[J]. JOURNAL OF HEPATOLOGY, 2008, 49 (04) : 505 - 506
[5] Sexual Orientation and Obesity: What Do We Know?
Nicole A. VanKim
Melissa N. Laska
[J]. Current Obesity Reports, 2021, 10 : 453 - 457
[6] Sexual Orientation and Obesity: What Do We Know?
VanKim, Nicole A.
Laska, Melissa N.
[J]. CURRENT OBESITY REPORTS, 2021, 10 (04) : 453 - 457
[7] ROLE OF THE LIVER IN THE METABOLIC CONTROL OF EATING - WHAT WE KNOW AND WHAT WE DO NOT KNOW
LANGHANS, W
[J]. APPETITE, 1994, 23 (03) : 312 - 313
[8] Role of the liver in the metabolic control of eating: What we know - And what we do not know
Langhans, W
[J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1996, 20 (01): : 145 - 153
[9] GLUCOCORTICOIDS IN RHEUMATIC DISEASES: WHAT DO WE KNOW?
Nesterenko, V. A.
Karateev, A. E.
Makarov, M. A.
Bialik, E. I.
Makarov, S. A.
Arkhipov, S. V.
Bialik, V. E.
Roskidailo, A. A.
Naryshkin, E. A.
Khramov, A. E.
Dubinin, A. O.
Maglevanny, S. V.
Filatova, E. S.
Polishchuk, E. Y.
[J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S212 - S213
[10] What we know and what we do not know
McDonald, JC
[J]. RADIATION PROTECTION DOSIMETRY, 2005, 113 (02) : 127 - 128

← 1 2 3 4 5 →